Enrichment of CD8+ CD28- cytotoxic T cells in circulating lymphocytes of patients with ankylosing spondylitis

Documenti analoghi

• Circulating cytotoxic CD8(+) CD28(-) T cells in ankylosing spondylitis
  di: Schirmer, Michael, et al.
  Pubblicazione: (2002)
• Prevalence, clinical relevance and characterization of circulating cytotoxic CD4(+)CD28(- )T cells in ankylosing spondylitis
  di: Duftner, Christina, et al.
  Pubblicazione: (2003)
• Preferential type 1 chemokine receptors and cytokine production of CD28(−) T cells in ankylosing spondylitis
  di: Duftner, C, et al.
  Pubblicazione: (2006)
• Between adaptive and innate immunity: TLR4-mediated perforin production by CD28(null) T-helper cells in ankylosing spondylitis
  di: Raffeiner, Bernd, et al.
  Pubblicazione: (2005)
• Regulation of inflammatory CD28(-) T-helper cells by HLA class I molecules: a new cellular model for Behçet's disease?
  di: Duftner, C, et al.
  Pubblicazione: (2003)